Publications

Preprints

Graham, E.J., Richmond, P.A., Tarailo-Graovac, M., Engelke, U., Kluijtmans, A.J., Coene, K.L.M., Wevers,R.A., Wasserman, W.W., van Karnebeek, C.D.M., Mostafavi, S. “metPropagate: network-guided propagation of metabolomic information for prioritization of neurometabolic disease genes.” Submitted. 2019 Dec.

Articles

Graham, E., Vermeulen, M., Vardarajan, B., Bennett, D., De Jager, P., Pearse, R., Young-Pearse, T.L., Mostafavi, S. “Somatic mosaicism of sex chromosomes in the blood and brain.” Brain Research. 2019 Oct.

Graham, E., Lee, J., Price, M., Tarailo-Graovac, M., Matthews, A., Engelke, Udo., Tang, J., Kluijtmans L., Wevers, Ron., Wasserman, W., van Karnebeek, C.D.M., Mostafavi, S. “Integration of genomics and metabolomics for prioritization of rare disease variants: A 2018 literature review.” Journal of Inherited Metabolic Disease. 2018 April.

Mahsa, J., Graham, E.J., Malinowski, J., Quinn, C.E., Carling, T., Udelsman, G., Callender, G.G. “Dissection of Levels II through V Is Required for Optimal Outcomes in Patients with Lateral Neck Lymph Node Metastasis from Papillary Thyroid Carcinoma.” Journal of the American College of Surgeons. 2016 Jun.

Alvero, A. B., Montagna, M. K., Sumi, N. J., Joo, W. D., Graham, E.J. and Mor, G. “Multiple Blocks in the Engagement of Oxidative Phosphorylation in Putative Ovarian Cancer Stem Cells: Implication for Maintenance Therapy with Glycolysis Inhibitors.” Oncotarget. 2014 Sept.

Conferences

Graham, E., Lee, J., Price, M., Tarailo-Graovac, M., Matthews, A., Engelke, Udo., Tang, J., Kluijtmans L., Wevers, Ron., Wasserman, W., van Karnebeek, C.D.M., Mostafavi, S. “Integration of genomics and metabolomics for prioritization of rare disease variants.” Wellcome Genome Trust Genomics of Rare Disease Conference. Short Talk. 2018 Mar.

Graham, E.J., J. Malinowski, C. A. Dinauer, E. R. Christison-Lagay, C. E. Quinn, T. Carling, and R. Udelsman. “Age and Anti-Thyroid Drug Intolerance Predict Definitive Therapy in Pediatric Graves Disease.” Academic Surgical Congress. QuickShot Presentation. 2016 Feb.

Javid, M., E. Graham, J. Malinowski, C. Quinn, T. Carling, R. Udelsman, and G. Callender. “Dissection of Levels II Through V Is Required for Optimal Outcome in Patients With Lateral Neck Lymph Node Metastasis From Differentiated Thyroid Carcinoma” Brief Report at the New England Surgical Society 96th Annual Meeting. Presented by Mahsa Javid.